Total Payments
$596,216
2024 Payments
$63,873
Companies
14
Transactions
1,040
Medicare Patients
650
Medicare Billing
$31,543
Payment Breakdown by Category
Other$412,790 (69.2%)
Travel$121,234 (20.3%)
Consulting$46,146 (7.7%)
Food & Beverage$16,006 (2.7%)
Education$39.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $409,414 | 190 | 68.7% |
| Travel and Lodging | $121,234 | 528 | 20.3% |
| Consulting Fee | $46,146 | 22 | 7.7% |
| Food and Beverage | $16,006 | 295 | 2.7% |
| Honoraria | $3,376 | 1 | 0.6% |
| Education | $39.56 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $235,504 | 391 | $0 (2024) |
| Allergan, Inc. | $99,219 | 202 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $82,794 | 131 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $57,060 | 88 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $45,039 | 117 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $32,636 | 47 | $0 (2018) |
| Lilly USA, LLC | $20,770 | 31 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $6,474 | 11 | $0 (2023) |
| UROVANT SCIENCES INC | $6,264 | 10 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $4,361 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63,873 | 108 | Neurocrine Biosciences, Inc. ($42,296) |
| 2023 | $73,282 | 134 | Neurocrine Biosciences, Inc. ($40,243) |
| 2022 | $47,408 | 93 | ACADIA Pharmaceuticals Inc ($35,299) |
| 2021 | $25,867 | 49 | ACADIA Pharmaceuticals Inc ($15,995) |
| 2020 | $16,544 | 22 | Lilly USA, LLC ($9,448) |
| 2019 | $82,440 | 146 | ACADIA Pharmaceuticals Inc ($33,795) |
| 2018 | $66,372 | 116 | ACADIA Pharmaceuticals Inc ($30,992) |
| 2017 | $220,429 | 372 | Allergan Inc. ($88,391) |
All Payment Transactions
1,040 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $203.52 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $377.30 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,563.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $522.95 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $278.66 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $126.08 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $104.76 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $87.74 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.56 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $16.81 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $276.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $40.77 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $100.37 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $78.95 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/08/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $465.41 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $641.26 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $635.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $307.05 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/03/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 14 | $1,386 | $303.37 |
| 2022 | 6 | 639 | 933 | $74,378 | $31,240 |
Total Patients
650
Total Services
947
Medicare Billing
$31,543
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 14 | $1,386 | $303.37 | 21.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 220 | 514 | $50,886 | $23,333 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 105 | 105 | $4,200 | $3,174 | 75.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 88 | 88 | $13,210 | $1,856 | 14.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 42 | 42 | $3,360 | $1,681 | 50.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 17 | 17 | $2,720 | $1,194 | 43.9% |
| 91312 | Coronavirus vaccine 13 | Office | 2022 | 167 | 167 | $1.76 | $1.67 | 94.9% |
About Dr. Malcolm Fraser, MD
Dr. Malcolm Fraser, MD is a Geriatric Medicine healthcare provider based in Brooksville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861486177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malcolm Fraser, MD has received a total of $596,216 in payments from pharmaceutical and medical device companies, with $63,873 received in 2024. These payments were reported across 1,040 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($409,414).
As a Medicare-enrolled provider, Fraser has provided services to 650 Medicare beneficiaries, totaling 947 services with total Medicare billing of $31,543. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Brooksville, FL
- Active Since 09/01/2005
- Last Updated 09/22/2014
- Taxonomy Code 207QG0300X
- Entity Type Individual
- NPI Number 1861486177
Products in Payments
- NUPLAZID (Drug) $235,504
- INGREZZA (Drug) $82,764
- NAMZARIC (Drug) $73,392
- XARELTO (Drug) $57,060
- Xtampza ER (Drug) $32,636
- LINZESS (Drug) $25,667
- LONHALA MAGNAIR (Drug) $21,979
- TRULICITY (Drug) $18,950
- APTIOM (Drug) $17,677
- GEMTESA (Drug) $12,739
- UTIBRON (Drug) $5,327
- DRIZALMA SPRINKLE (Drug) $3,376
- REXULTI (Drug) $2,400
- NUEDEXTA (Drug) $220.92
- NAMENDA XR (Drug) $137.24
- AUSTEDO (Drug) $119.55
- MYRBETRIQ (Drug) $118.62
- Myrbetriq (Drug) $52.60
- BROVANA (Drug) $43.36
- Ongentys (Drug) $29.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.